MONTPELLIER

The "Spring Festival Festival Festival" in Chengdu has come to an end

Retrieved on: 
Jeudi, février 29, 2024
Education, Culture, City, China Global Television Network, Chairperson, Wave, Lantern Festival, Tencent, Spring Festival, VR, Animation, Beauty, Social media, The Spring Festival, Twin Towers, Tourism, Nanyang Technological University, All Nations, Taste, International University Sports Federation, WeChat, Multimedia, Ice, Cultural attaché, Witness, Mass migration, Diplomatic mission, Sport, Snow, Hot Cities, Lantern, Internet, New Spring, AI, Friends, Year of the Dragon, Consul, Lunar New Year, CGTN, Hanfu, Painting, Athlete, Chinese New Year

CHENGDU, China, Feb. 28, 2024 /PRNewswire/ -- On the night of February 24th, the lanterns in Chengdu were bright and dazzling, with countless Spring Festival activities blooming in various places in Chengdu. The Year of the Dragon came to a close amidst the lively atmosphere of fireworks and excitement, marking a vibrant start to the Chinese people's 2024. In the midst of this festive tourism atmosphere, how "hot and spicy" is Chengdu?

Key Points: 
  • Statistics show that during the Spring Festival period, GoChengdu ranked first on both Facebook and X platforms among national central city accounts.
  • On Lantern Festival day, GoChengdu released the creative short film "Strolling in the December Market Painting," capturing the festive atmosphere of Lantern Festival in Chengdu.
  • The short film creatively uses VR gaming settings to recreate the prosperous scene of the December market in Song Dynasty Chengdu.
  • On the Xiaohongshu platform, there are over 1.64 million notes recording the "Chengdu Spring Festival Travel Guide," inspiring global netizens to explore Chengdu through the internet.

Pianist Mina Cho Solidifies Her Unique Fusion of Jazz with Korean Traditional Music on "Beat Mirage," Set for February 9 Release

Retrieved on: 
Jeudi, janvier 4, 2024
Destiny, Yonsei University, Trinity Church, Mirage, Map, Paul the Apostle, Theology, Multimedia, Catharsis, Season, Museum, Love, Moon, Berklee College of Music, Cho, Life, Nightclub

RICHMOND, Calif., Jan. 4, 2024 /PRNewswire-PRWeb/ -- Mina Cho's startlingly fresh approach to jazz fusion reaches its culmination with "Beat Mirage," her fifth album and the debut of her Grace Beat Quartet. Supported by bassist Max Ridley, drummer Yeongjin Kim and percussionist Insoo Kim, the Boston (by way of Seoul) pianist and composer makes bold new strides in her career-long quest to bridge the musical traditions of Korean gugak and American jazz.

Key Points: 
  • The deeper that Boston-based pianist Mina Cho delves into her Korean roots, the more personal and distinctive her music becomes.
  • Brought together, they form an imaginative range of sonics that "often blend notated amalgamations of Korean and jazz rhythms."
  • She earned a scholarship to Boston's Berklee College of Music to study the music formally, a pursuit that led her to discover jazz.
  • Updates on the upcoming performances for the CD release concerts and Canada-Korea Co-Creation Project will be announced on the website.

DataBank Completes Sale of French Data Center Assets to Etix Everywhere

Retrieved on: 
Lundi, octobre 2, 2023
Sale, Data, Intelligence, Guggenheim Partners, Cryptocurrency

DALLAS, Oct. 2, 2023 /PRNewswire/ -- DataBank, a leading provider of enterprise-class edge colocation, interconnection, and managed services, announced today that it has completed the sale of its five data centers in France (operating as "zColo France SAS") to Etix Everywhere, a major edge data center player in Europe and Asia.  DataBank initially acquired the French data centers as part of the zColo transaction in 2020. 

Key Points: 
  • DataBank initially acquired the French data centers as part of the zColo transaction in 2020.
  • The completion of the transaction allows DataBank to fully focus on its core U.S. market, which is served by 65+ facilities in 27+ markets.
  • "We are glad to complete the sale of our French assets to Etix Everywhere, and have our French customers and employees join a platform extremely focused on the European market," said Raul Martynek, DataBank's CEO.
  • Guggenheim Partners served as financial advisor to DataBank in connection with the transaction and Delsol Avocats served as legal counsel.

DataBank Announces Definitive Agreement to Sell French Data Center Assets to Etix Everywhere

Retrieved on: 
Lundi, juillet 3, 2023
Data, Eureka Transit Service, TSA, Guggenheim Partners, Cryptocurrency

DALLAS, July 3, 2023 /PRNewswire/ -- DataBank, a leading provider of enterprise-class edge colocation, interconnection, and managed services, announced today that it has entered into an agreement to sell its five data centers in France (operating as "zColo France SAS") to Etix Everywhere, an operator with edge data centers in France and Belgium. DataBank initially acquired the French data centers as part of the zColo transaction in 2020.

Key Points: 
  • DataBank initially acquired the French data centers as part of the zColo transaction in 2020.
  • "This transaction allows DataBank to focus capital and resources on our core U.S. market," said Raul Martynek, DataBank's CEO.
  • Guggenheim Partners is serving as financial advisor to DataBank in connection with the transaction and Delsol Avocats is serving as legal counsel.
  • ODDO BHF is acting as the financial advisor to Etix Everywhere, and Herbert Smith Freehills is serving as legal advisor.

 Septeo French Tech reference recorded 310 million euros revenues up to 30% compared to 2021 and joins top 10 software players in France

Retrieved on: 
Mercredi, février 22, 2023
Banking, Software, Professional Services, Fintech, Data Management, Technology, Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Legal, Finance, Other Technology, Casus foederis, Business intelligence software, Acquisition, Investment, Growth, Acceleration, HR, Fruit, Science and technology in Asia, Property, Fine chemical

As one of the largest private employers in the Montpellier employment area, Septeo is pursuing its intensive growth strategy.

Key Points: 
  • As one of the largest private employers in the Montpellier employment area, Septeo is pursuing its intensive growth strategy.
  • Hugues Galambrun, founder and CEO of Septeo, comments this achievement : « The winning strategy we have been pursuing since 2020 is bearing fruit.
  • The ambition remains to become one of the leading tech companies in France within the next 3 years.
  • Beyond the regulated professions, Septeo is becoming a reference in the real estate sector, but also for businesses.

Anti-Cancer Potential of Rencofilstat Expanded with Results from Preclinical Multiple Myeloma Studies

Retrieved on: 
Mercredi, janvier 18, 2023
Degenerative disease, Gene expression, Cell, Prostate cancer, Cancer, Multiple myeloma, Fatty liver disease, Doctor of Pharmacy, Conditional sentence, Bortezomib, HEPA, Immortalised cell line, Research, Fibrosis, Liver cancer, Artificial intelligence, Transfusion-related acute lung injury, Doctor of Philosophy, NASH, Pharmaceutical industry, Vaccine

EDISON, N.J., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”), and other chronic diseases, today announced positive results of preclinical studies examining rencofilstat as a potential therapeutic for multiple myeloma (“MM”).

Key Points: 
  • Rencofilstat exerted anti-cancer activity across a large panel of MM cell lines, and most potently, in combination with bortezomib, a proteosome inhibitor and first-line treatment for MM.
  • These results strengthen Hepion’s oncology initiatives and further support rencofilstat’s poly-indication potential.
  • The combination of rencofilstat and bortezomib produced 100% cytotoxicity in cell culture experiments across all 16 MM cell lines, including three lines that are characterized as bortezomib-resistant.
  • The cytotoxic activity of rencofilstat plus bortezomib was synergistic in every cell line, showing greater cytotoxicity in combination than the sum of the two drugs individually.

DGAP-News: Abivax phase 2a study results of obefazimod (ABX464) in rheumatoid arthritis published in the journal “Annals of the Rheumatic Diseases” and selected for presentation at EULAR 2022

Retrieved on: 
Mardi, juin 7, 2022
USAN, Physiology, EST, Congress, EULAR, Ulcerative colitis, INN, Euronext Paris, FAS, RA, CEST, MTX, Inflammation, CEO, WHO, Maintenance, Therapy, United States Adopted Name, ARD, University Hospital (Newark, New Jersey), Degenerative disease, Hepatocellular carcinoma, ISIN, Patient, ACR20, Immune system, Rheumatoid arthritis, Twitter, Population, Teaching hospital, Infection, Cancer, Safety, Methotrexate, Pharmaceutical industry, Medical device, Generic drug, Abivax, Euronext, UC, Rheumatology, Fellow of the Academy of Medical Sciences

Further, the abstract on these phase 2a data has been selected for a poster presentation at the Annual European Congress of Rheumatology, EULAR 2022.

Key Points: 
  • Further, the abstract on these phase 2a data has been selected for a poster presentation at the Annual European Congress of Rheumatology, EULAR 2022.
  • I am looking forward to presenting obefazimod and its promising results to the international expert community, also taking into account the recently published very encouraging phase 2a one-year maintenance results in RA.
  • There is still a high unmet medical need for safe and durably efficient therapies for rheumatoid arthritis patients.
  • In June 2021, Abivax communicated the results of the induction phase of its phase 2a clinical study .

Transgene’s Combined General Meeting of May 25, 2022

Retrieved on: 
Mercredi, mai 25, 2022
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Medicine, Research, Claude Bernard University Lyon 1, European Society for Medical Oncology, University, SPH, Artificial intelligence, Risk, AstraZeneca, Oncology, Novartis, Medical Affairs Bureau, Immunotherapy, European Commission, Kite Pharma, List of life sciences, Therapy, Marketing, Institute, Vaccination, Century, EVP, Acquisition, Growth, Potyvirus, University of Milan, MDL, Doctor of Philosophy, AMF, Director general, National academy, Adult, TNG, Hematology, Corporate law, ESMO, Cell, European Organization for Quality, Transgene, Ernst & Young, Board, Law, Patient, Treatment, Ernst, NEC, National Cancer Institute, Forward-looking statement, European Commission–AstraZeneca COVID-19 vaccine dispute, Precision medicine, Gilead Sciences, CEO, Pharmaceutical industry, Vaccine, Cancer, Axicabtagene ciloleucel, Euronext, EU

Detailed voting results are available on Transgenes website, under the heading Investors > General Meeting.

Key Points: 
  • Detailed voting results are available on Transgenes website, under the heading Investors > General Meeting.
  • Prior to Gilead, Dr. Riva was EVP, Global Head of Oncology Development and Medical Affairs at Novartis Pharmaceuticals.
  • Jean-Yves Blay is Professor of Medical Oncology and has been General Director of the Lon Brard Center in Lyon since 2014.
  • With Transgenes myvac platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully tailored to each individual.

Fuel Cells Are Not the Problem, the Hydrogen Fuel Is, Says IDTechEx

Retrieved on: 
Lundi, février 14, 2022
NEXO, Subscription business model, CO2, Adoption, Water, PEM, Reading, Research, Hydrogen, Carbon, Consultant, Atmosphere, Electrolysis, Hynam, South Australia, Intention, Honda, Natural gas, Sale, Hyundai, Growth, Hyundai ix35 FCEV, EDF, FCEV, Electricity, Face, City, Motor vehicle, Renewable energy, Coal

To sweeten the deal further, Toyota also offered a $15k fuel credit for the first three years of operation.

Key Points: 
  • To sweeten the deal further, Toyota also offered a $15k fuel credit for the first three years of operation.
  • A $50k car for less than $20k with 100,000 kilometers of free fuel is undoubtedly an appealing deal.
  • PEM fuel cells, using pressurized gaseous hydrogen as fuel, can deliver a greater range and quicker refueling time than equivalent battery electric vehicles.
  • IDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies.

Fuel Cells Are Not the Problem, the Hydrogen Fuel Is, Says IDTechEx

Retrieved on: 
Lundi, février 14, 2022
NEXO, Subscription business model, CO2, Adoption, Water, PEM, Reading, Research, Hydrogen, Carbon, Consultant, Atmosphere, Electrolysis, Hynam, South Australia, Intention, Honda, Natural gas, Sale, Hyundai, Growth, Hyundai ix35 FCEV, EDF, FCEV, Electricity, Face, City, Motor vehicle, Renewable energy, Coal

To sweeten the deal further, Toyota also offered a $15k fuel credit for the first three years of operation.

Key Points: 
  • To sweeten the deal further, Toyota also offered a $15k fuel credit for the first three years of operation.
  • A $50k car for less than $20k with 100,000 kilometers of free fuel is undoubtedly an appealing deal.
  • PEM fuel cells, using pressurized gaseous hydrogen as fuel, can deliver a greater range and quicker refueling time than equivalent battery electric vehicles.
  • IDTechEx guides your strategic business decisions through its Research, Subscription and Consultancy products, helping you profit from emerging technologies.